Selected research
Industry Growth & Trends
Global Mosapride Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Mosapride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Mosapride market include DAIICHI SANKYO, Dainippon Pharmaceutical Co., Ltd., Nihon Generic, NIPPON CHEMIPHAR CO., LTD., SAWAI PHARMACEUTICAL CO., LTD., Sumitomo Dainippon Pharma, Konghong Pharmaceutical, HAOSON PHARMA and Lunan Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Mosapride market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Mosapride market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mosapride market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mosapride.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Mosapride market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Mosapride Market by Company
DAIICHI SANKYO
Dainippon Pharmaceutical Co., Ltd.
Nihon Generic
NIPPON CHEMIPHAR CO., LTD.
SAWAI PHARMACEUTICAL CO., LTD.
Sumitomo Dainippon Pharma
Konghong Pharmaceutical
HAOSON PHARMA
Lunan Pharmaceutical Group
Mosapride Segment by Type
Tablet
Capsule
Others
Mosapride Segment by Application
Gastritis
Dyspepsia
Others
Mosapride Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mosapride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mosapride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mosapride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Mosapride companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
- Others
Applications
- Gastritis
- Dyspepsia
- Others
Companies covered
- DAIICHI SANKYO
- Dainippon Pharmaceutical Co., Ltd.
- Nihon Generic
- NIPPON CHEMIPHAR CO., LTD.
- SAWAI PHARMACEUTICAL CO., LTD.
- Sumitomo Dainippon Pharma
- Konghong Pharmaceutical
- HAOSON PHARMA
- Lunan Pharmaceutical Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Mosapride Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Mosapride Market Size by Region (2021-2032)
- 1.4.1 Global Mosapride Market Size by Region (2021-2026)
- 1.4.2 Global Mosapride Market Size by Region (2027-2032)
- 1.5 Key Regions Mosapride Market Size (2021-2032)
- 1.5.1 North America Mosapride Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Mosapride Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Mosapride Market Size Growth Rate (2021-2032)
- 1.5.4 South America Mosapride Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Mosapride Market Size Growth Rate (2021-2032)
2 Mosapride Market by Type
- 2.1 Type Introduction
- 2.1.1 Tablet
- 2.1.2 Capsule
- 2.1.3 Others
- 2.2 Global Mosapride Market Size by Type
- 2.2.1 Global Mosapride Market Size Overview by Type (2021-2032)
- 2.2.2 Global Mosapride Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Mosapride Market Size Forecasted by Type (2027-2032)
- 2.3 Global Mosapride Market Size by Regions
- 2.3.1 North America Mosapride Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Mosapride Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Mosapride Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Mosapride Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Mosapride Market Size Breakdown by Type (2021-2026)
3 Mosapride Market by Application
- 3.1 Type Introduction
- 3.1.1 Gastritis
- 3.1.2 Dyspepsia
- 3.1.3 Others
- 3.2 Global Mosapride Market Size by Application
- 3.2.1 Global Mosapride Market Size Overview by Application (2021-2032)
- 3.2.2 Global Mosapride Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Mosapride Market Size Forecasted by Application (2027-2032)
- 3.3 Global Mosapride Market Size by Regions
- 3.3.1 North America Mosapride Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Mosapride Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Mosapride Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Mosapride Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Mosapride Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Mosapride Industry Trends
- 4.2 Mosapride Industry Drivers
- 4.3 Mosapride Industry Opportunities and Challenges
- 4.4 Mosapride Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Mosapride Revenue (2021-2026)
- 5.2 Global Mosapride Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Mosapride Key Company Headquarters & Area Served
- 5.4 Global Mosapride Company, Product Type & Application
- 5.5 Global Mosapride Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Mosapride Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Mosapride Players Market Share by Revenue in 2025
- 5.6.3 2025 Mosapride Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 DAIICHI SANKYO
- 6.1.1 DAIICHI SANKYO Company Information
- 6.1.2 DAIICHI SANKYO Business Overview
- 6.1.3 DAIICHI SANKYO Mosapride Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 DAIICHI SANKYO Mosapride Product Portfolio
- 6.1.5 DAIICHI SANKYO Recent Developments
- 6.2 Dainippon Pharmaceutical Co., Ltd.
- 6.2.1 Dainippon Pharmaceutical Co., Ltd. Company Information
- 6.2.2 Dainippon Pharmaceutical Co., Ltd. Business Overview
- 6.2.3 Dainippon Pharmaceutical Co., Ltd. Mosapride Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Dainippon Pharmaceutical Co., Ltd. Mosapride Product Portfolio
- 6.2.5 Dainippon Pharmaceutical Co., Ltd. Recent Developments
- 6.3 Nihon Generic
- 6.3.1 Nihon Generic Company Information
- 6.3.2 Nihon Generic Business Overview
- 6.3.3 Nihon Generic Mosapride Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Nihon Generic Mosapride Product Portfolio
- 6.3.5 Nihon Generic Recent Developments
- 6.4 NIPPON CHEMIPHAR CO., LTD.
- 6.4.1 NIPPON CHEMIPHAR CO., LTD. Company Information
- 6.4.2 NIPPON CHEMIPHAR CO., LTD. Business Overview
- 6.4.3 NIPPON CHEMIPHAR CO., LTD. Mosapride Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 NIPPON CHEMIPHAR CO., LTD. Mosapride Product Portfolio
- 6.4.5 NIPPON CHEMIPHAR CO., LTD. Recent Developments
- 6.5 SAWAI PHARMACEUTICAL CO., LTD.
- 6.5.1 SAWAI PHARMACEUTICAL CO., LTD. Company Information
- 6.5.2 SAWAI PHARMACEUTICAL CO., LTD. Business Overview
- 6.5.3 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Product Portfolio
- 6.5.5 SAWAI PHARMACEUTICAL CO., LTD. Recent Developments
- 6.6 Sumitomo Dainippon Pharma
- 6.6.1 Sumitomo Dainippon Pharma Company Information
- 6.6.2 Sumitomo Dainippon Pharma Business Overview
- 6.6.3 Sumitomo Dainippon Pharma Mosapride Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Sumitomo Dainippon Pharma Mosapride Product Portfolio
- 6.6.5 Sumitomo Dainippon Pharma Recent Developments
- 6.7 Konghong Pharmaceutical
- 6.7.1 Konghong Pharmaceutical Company Information
- 6.7.2 Konghong Pharmaceutical Business Overview
- 6.7.3 Konghong Pharmaceutical Mosapride Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Konghong Pharmaceutical Mosapride Product Portfolio
- 6.7.5 Konghong Pharmaceutical Recent Developments
- 6.8 HAOSON PHARMA
- 6.8.1 HAOSON PHARMA Company Information
- 6.8.2 HAOSON PHARMA Business Overview
- 6.8.3 HAOSON PHARMA Mosapride Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 HAOSON PHARMA Mosapride Product Portfolio
- 6.8.5 HAOSON PHARMA Recent Developments
- 6.9 Lunan Pharmaceutical Group
- 6.9.1 Lunan Pharmaceutical Group Company Information
- 6.9.2 Lunan Pharmaceutical Group Business Overview
- 6.9.3 Lunan Pharmaceutical Group Mosapride Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Lunan Pharmaceutical Group Mosapride Product Portfolio
- 6.9.5 Lunan Pharmaceutical Group Recent Developments
7 North America
- 7.1 North America Mosapride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Mosapride Market Size by Country (2021-2026)
- 7.3 North America Mosapride Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Mosapride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Mosapride Market Size by Country (2021-2026)
- 8.3 Europe Mosapride Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Mosapride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Mosapride Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Mosapride Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Mosapride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Mosapride Market Size by Country (2021-2026)
- 10.3 South America Mosapride Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Mosapride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Mosapride Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Mosapride Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst